6-87473010-G-T

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_006416.5(SLC35A1):​c.7G>T​(p.Ala3Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00368 in 682,164 control chromosomes in the GnomAD database, including 45 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A3T) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.013 ( 37 hom., cov: 33)
Exomes 𝑓: 0.0011 ( 8 hom. )

Consequence

SLC35A1
NM_006416.5 missense

Scores

18

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:3

Conservation

PhyloP100: -0.137

Publications

2 publications found
Variant links:
Genes affected
SLC35A1 (HGNC:11021): (solute carrier family 35 member A1) The protein encoded by this gene is found in the membrane of the Golgi apparatus, where it transports nucleotide sugars into the Golgi. One such nucleotide sugar is CMP-sialic acid, which is imported into the Golgi by the encoded protein and subsequently glycosylated. Defects in this gene are a cause of congenital disorder of glycosylation type 2F (CDG2F). Two transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Dec 2009]
SLC35A1 Gene-Disease associations (from GenCC):
  • SLC35A1-congenital disorder of glycosylation
    Inheritance: AR Classification: STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0014354289).
BP6
Variant 6-87473010-G-T is Benign according to our data. Variant chr6-87473010-G-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 95393.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0125 (1910/152332) while in subpopulation AFR AF = 0.0423 (1759/41578). AF 95% confidence interval is 0.0407. There are 37 homozygotes in GnomAd4. There are 891 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 37 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC35A1NM_006416.5 linkc.7G>T p.Ala3Ser missense_variant Exon 1 of 8 ENST00000369552.9 NP_006407.1 P78382-1
SLC35A1NM_001168398.2 linkc.7G>T p.Ala3Ser missense_variant Exon 1 of 7 NP_001161870.1 P78382-2
LOC124901357XR_007059668.1 linkn.-65C>A upstream_gene_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC35A1ENST00000369552.9 linkc.7G>T p.Ala3Ser missense_variant Exon 1 of 8 1 NM_006416.5 ENSP00000358565.4 P78382-1
ENSG00000213204ENST00000507897.5 linkn.*61-4352G>T intron_variant Intron 13 of 15 2 ENSP00000426769.1

Frequencies

GnomAD3 genomes
AF:
0.0125
AC:
1898
AN:
152214
Hom.:
37
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0421
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00811
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000118
Gnomad OTH
AF:
0.00860
GnomAD2 exomes
AF:
0.00364
AC:
58
AN:
15946
AF XY:
0.00222
show subpopulations
Gnomad AFR exome
AF:
0.0341
Gnomad AMR exome
AF:
0.00335
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00376
GnomAD4 exome
AF:
0.00113
AC:
600
AN:
529832
Hom.:
8
Cov.:
7
AF XY:
0.000928
AC XY:
251
AN XY:
270430
show subpopulations
African (AFR)
AF:
0.0390
AC:
443
AN:
11352
American (AMR)
AF:
0.00410
AC:
36
AN:
8772
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
12070
East Asian (EAS)
AF:
0.00
AC:
0
AN:
24536
South Asian (SAS)
AF:
0.0000977
AC:
3
AN:
30696
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
29780
Middle Eastern (MID)
AF:
0.000607
AC:
2
AN:
3294
European-Non Finnish (NFE)
AF:
0.0000444
AC:
17
AN:
383110
Other (OTH)
AF:
0.00378
AC:
99
AN:
26222
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
27
55
82
110
137
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0125
AC:
1910
AN:
152332
Hom.:
37
Cov.:
33
AF XY:
0.0120
AC XY:
891
AN XY:
74500
show subpopulations
African (AFR)
AF:
0.0423
AC:
1759
AN:
41578
American (AMR)
AF:
0.00810
AC:
124
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5174
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10630
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000118
AC:
8
AN:
68026
Other (OTH)
AF:
0.00851
AC:
18
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
86
172
259
345
431
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00392
Hom.:
1
Bravo
AF:
0.0143
ESP6500AA
AF:
0.0317
AC:
127
ESP6500EA
AF:
0.000126
AC:
1
ExAC
AF:
0.00194
AC:
197
Asia WGS
AF:
0.00260
AC:
9
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:1
Oct 11, 2016
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 06, 2017
Eurofins Ntd Llc (ga)
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Feb 22, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

SLC35A1-congenital disorder of glycosylation Benign:1
Dec 08, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.090
BayesDel_addAF
Benign
-0.63
T
BayesDel_noAF
Benign
-0.65
CADD
Benign
12
DANN
Benign
0.96
DEOGEN2
Benign
0.0050
.;T;T
Eigen
Benign
-0.83
Eigen_PC
Benign
-0.78
FATHMM_MKL
Benign
0.055
N
LIST_S2
Benign
0.72
T;T;T
MetaRNN
Benign
0.0014
T;T;T
MetaSVM
Benign
-0.96
T
MutationAssessor
Benign
0.41
N;.;N
PhyloP100
-0.14
PrimateAI
Benign
0.38
T
PROVEAN
Benign
-0.020
N;N;N
REVEL
Benign
0.060
Sift
Benign
0.38
T;T;T
Sift4G
Benign
0.46
T;T;T
Polyphen
0.0
.;.;B
Vest4
0.14
MVP
0.22
MPC
0.31
ClinPred
0.0068
T
GERP RS
2.2
PromoterAI
-0.23
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.6
Varity_R
0.050
gMVP
0.22
Mutation Taster
=298/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs149903512; hg19: chr6-88182728; COSMIC: COSV107470392; COSMIC: COSV107470392; API